Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.91 and has seen 2.0 million shares traded in the last trading session. The company, currently
In today’s recent session, 0.46 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) have been traded, and its beta is -0.91. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 0.74 million during the latest session, with the company’s beta value hitting -0.91. At the last check
In the latest trading session, 2.4 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.91. With the company’s most recent
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.92 and has seen 1.51 million shares traded in the last trading session. The company, currently
During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 0.61 million, with the beta value of the company hitting -0.91. At the end
In today’s recent session, 0.44 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) have been traded, and its beta is -0.91. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 1.85 million during the last session, with the company’s beta value hitting -0.91. At the close of
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 1.9 million during the last session, with the company’s beta value hitting -0.89. At the close of
In the latest trading session, 0.64 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -0.88. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
